GSK Plc (GSK)
48.22
-0.90
(-1.83%)
USD |
NYSE |
Jan 16, 16:00
48.03
-0.19
(-0.39%)
Pre-Market: 08:58
GSK Free Cash Flow: 5.645B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| AstraZeneca PLC | 9.870B |
| Biodexa Pharmaceuticals Plc | -14.30M |
| AnaptysBio, Inc. | -145.42M |
| NuCana Plc | -18.19M |
| Mereo BioPharma Group Plc | -33.02M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.028B |
| Cash from Investing (Quarterly) | -2.150B |
| Cash from Financing (Quarterly) | -1.707B |
| Free Cash Flow Per Share (Quarterly) | 0.8897 |
| Free Cash Flow to Equity (Quarterly) | 1.710B |
| Free Cash Flow to Firm (Quarterly) | 2.021B |
| Free Cash Flow Yield | 5.68% |